ABemaciclib, ET ± paclItaxel in aGgressive HR+/HER2- MBC trIaL

Clinical trial NCT04603183 · COMPLETED

Trial details

NCT number: NCT04603183
Sponsor: MedSIR
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Metastatic

Start date: 2021-06-02
Primary completion: 2024-06-30
Enrollment: 162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.